Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,724
datasets available to search
ShareScore release 0.9.0
Dataset results
1,724 results for “ESCALATOR”
An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors
ClinicalTrials.gov study NCT00280397. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT05384587. IPD Sharing: YES. Countries: 1. Publications: 1.
A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endo
ClinicalTrials.gov study NCT01296555. IPD Sharing: Not stated. Countries: 4. Publications: 1.
RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA
ClinicalTrials.gov study NCT01497808. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT02129205. IPD Sharing: NO. Countries: 1. Publications: 1.
Triggered Escalating Real-time Adherence (TERA) Intervention
ClinicalTrials.gov study NCT03292432. IPD Sharing: NO. Countries: 1. Publications: 3.
AZD9773 Dose Escalation Study
ClinicalTrials.gov study NCT00615017. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms
ClinicalTrials.gov study NCT02163226. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01594125. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)
ClinicalTrials.gov study NCT00777296. IPD Sharing: Not stated. Countries: 7. Publications: 3.
Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease
ClinicalTrials.gov study NCT02023866. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer
ClinicalTrials.gov study NCT04608409. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL
ClinicalTrials.gov study NCT01544348. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
ClinicalTrials.gov study NCT02869295. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Crohn Disease Exclusion Diet After Single Medication De-escalation
ClinicalTrials.gov study NCT02472457. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
ClinicalTrials.gov study NCT03708328. IPD Sharing: NO. Countries: 6. Publications: 0.
A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia
ClinicalTrials.gov study NCT04085523. IPD Sharing: Not stated. Countries: 8. Publications: 1.
First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid Tumors
ClinicalTrials.gov study NCT01014936. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Natalizumab De-escalation With Interferon Beta-1b
ClinicalTrials.gov study NCT01144052. IPD Sharing: Not stated. Countries: 1. Publications: 10.
A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT02236000. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.